Citicoline in Youth Alcohol Use Disorder

Last updated: October 2, 2025
Sponsor: Medical University of South Carolina
Overall Status: Active - Recruiting

Phase

2

Condition

Alcohol Use Disorder

Substance Abuse

Alcohol Dependence

Treatment

Citicoline (cytidine diphosphate-choline)

Placebo oral capsule

Clinical Study ID

NCT05870111
Pro00128800
  • Ages 16-22
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this study is to evaluate how citicoline, an over-the-counter supplement, versus a placebo pill (i.e., an inactive pill) affects the immune system, brain, and cognition in adolescents who may use alcohol.

Eligibility Criteria

Inclusion

Inclusion:

Age 16 to 22.

Call study team for additional screening and information.

Study Design

Total Participants: 56
Treatment Group(s): 2
Primary Treatment: Citicoline (cytidine diphosphate-choline)
Phase: 2
Study Start date:
October 01, 2024
Estimated Completion Date:
February 28, 2029

Connect with a study center

  • Medical University of South Carolina

    Charleston, South Carolina 29425
    United States

    Site Not Available

  • Medical University of South Carolina

    Charleston 4574324, South Carolina 4597040 29425
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.